Watchlist Price Alert

Entrada Therapeutics Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

7.38

-0.03 (-0.40%)

At close: Jun 17, 2025, 10:06 AM

Entrada Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	65.63M	-6.68M	-94.62M	-51.16M	-26.52M	-5.1M
Depreciation & Amortization	3.77M	2.84M	1.9M	1.12M	326K	104K
Stock-Based Compensation	17.91M	13.11M	9.89M	2.53M	325K	294K
Other Working Capital	-122.04M	139.12M	-16.4M	-2.71M	-349K	-193K
Other Non-Cash Items	-10.02M	-5.78M	151K	74K	20K	-6.27M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-118.85M	136.31M	-11.11M	-3.42M	282K	174K
Operating Cash Flow	-41.56M	139.8M	-93.79M	-50.86M	-25.57M	-10.8M
Capital Expenditures	-3.16M	-5.61M	-2.89M	-4.58M	-2.33M	-630K
Cash Acquisitions	n/a	n/a	145.76M	n/a	7K	n/a
Purchase of Investments	-437.72M	-407.21M	-221.98M	n/a	n/a	n/a
Sales Maturities Of Investments	413.08M	274.43M	76.21M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-145.76M	n/a	n/a	n/a
Investing Cash Flow	-27.8M	-138.4M	-148.65M	-4.58M	-2.32M	-630K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	284K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.36M	1.63M	479K	939K	247K	38K
Financial Cash Flow	102.96M	21.04M	479K	307.46M	50.09M	38K
Net Cash Flow	33.61M	22.45M	-241.96M	252.02M	22.2M	-11.39M
Free Cash Flow	-44.72M	134.19M	-96.67M	-55.44M	-27.89M	-11.43M